Illumina (ILMN) Stock Price & AI Analysis

NYSE
USA

$141.09

$1.15
(1.47%)

Subscribe to get
AI Score

Illumina Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm’s products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm’s products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Illumina | Latest news

Illumina (ILMN) Down 9.3% Since Last Earnings Report: Can It Rebound?

It has been about a month since the last earnings report for Illumina (ILMN). Shares have lost about...

Zacks - 3 days ago

Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by Townsquare Capital LLC

Townsquare Capital LLC grew its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 28.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

ETF DAILY NEWS - 6 days ago

Private Trust Co. NA Has $62,000 Stake in Illumina, Inc. (NASDAQ:ILMN)

Private Trust Co. NA lifted its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 81.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional ...

ETF DAILY NEWS - 7 days ago

Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50...

Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and...

Quartz - 1 day ago

This startup says it can screen for over 50 cancers with one simple blood draw

Function Health, a lab tests startup, announced today that its members will now have access to early...

Quartz - 3 days ago

Illumina, Inc. (NASDAQ:ILMN) Holdings Decreased by The Manufacturers Life...

The Manufacturers Life Insurance Company trimmed its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 17.7% during the 3rd quarter, according to its most recent disclosure ...

ETF DAILY NEWS - 6 days ago

GenomeWeb Top 40 Rises 3 Percent in November Amidst Mixed Broader Market

In comparison, the Dow Jones Industrial Average rose 8 percent and the Nasdaq rose 6 percent, but the Nasdaq Biotech Index was in negative territory, falling by less than 1 percent.

GenomeWeb News - 5 days ago

Superstar singer signs for lifetime residency off Las Vegas Strip

Popular 1970's superstar singer accepts lifetime residency in Las Vegas. Legendary rock star Carlos...

TheStreetcom - 3 days ago

Should SPDR S&P MidCap 400 ETF (MDY) Be on Your Investing Radar?

Financials and Consumer Discretionary round out the top three. Looking at individual holdings,...

Zacks - 2 days ago

Fund manager's stock-pick focus includes a key Nvidia partner

A Causeway Capital fund manager sees big opportunity in a particular region.

TheStreetcom - 6 days ago